Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Total saponins from rehmannia leaves are a group of bioactive glycoside compounds extracted specifically from the leaves of *Rehmannia glutinosa*, a plant widely used in traditional Chinese medicine. Saponins are known for their surfactant properties and diverse biological activities, including anti-inflammatory, immunomodulatory, antioxidant, and potential nephroprotective effects. While most research on *Rehmannia glutinosa* focuses on its roots (rich in iridoid glycosides like catalpol), the leaf-derived saponin fraction has been studied for its pharmacological actions such as reducing proteinuria in nephritis models and modulating immune responses[9][7]. The mechanism of action is not fully elucidated but may involve modulation of inflammatory pathways and inhibition of enzymes like α-glucosidase[8][10]. These extracts are primarily investigated as experimental agents or dietary supplements rather than approved pharmaceuticals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on total saponins from rehmannia leaves.